# Aerogen and CanSinoBIO partner for inhaled COVID-19 vaccine delivery

Aerogen and CanSinoBIO announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO's Convidecia COVID-19 vaccine using Aerogen's vibrating mesh nebulizer technology.

- Type: Partnership
- Announced: 2021-12-09
- Status: announced
- Products: inhaled COVID-19 vaccine delivery system, vibrating mesh nebulizer
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Aerogen](https://endata.com/companies/59583.md) (partner)
- [CanSinoBIO](https://endata.com/companies/59584.md) (partner)

## Sources

- [businesswire.com](https://www.businesswire.com/news/home/20211208006016/en/Aerogen%c2%ae-and-CanSinoBIO-agree-on-landmark-development-and-commercial-supply-partnership-for-world%e2%80%99s-first-inhaled-Covid-19-vaccine-delivery), 2021-12-09: "Aerogen and CanSinoBIO agree landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.